DLD Video

Sir Ronald Cohen, Michael Diederich, Elisabeth Löwenbourg-Brzezinski, impact investing

Speakers

Sir Ronald Cohen

Global Steering Group for Impact Investment
Portrait of Sir Ronald Cohen, pioneer of impact investing

Sir Ronald Cohen is recognized as the father of impact investment. A pioneering philanthropist, venture capitalist and social innovator, he serves as Chairman of the Global Steering Group for Impact Investment, the Impact-Weighted Accounts Initiative at Harvard Business School and The Portland Trust. Sir Ronald was born in Egypt and left as a refugee at the age of 11, when his family came to the UK. He is the author of Impact: Reshaping Capitalism to Drive Real Change.

Profile Page

Michael Diederich

FC Bayern München AG
Portrait photo of Michael Diederich, Executive Vice Chairman of FC Bayern München AG.

Michael Diederich is Executive Vice Chairman and Chief Financial Officer of FC Bayern München AG. From 2018 to 2023 he served as CEO of HypoVereinsbank, a unit of Unicredit Group. In this function, he was a member of the group executive committee of the banking group in Milan.

Profile Page

Elisabeth Löwenbourg-Brzezinski

Acton Capital
Elisabeth Löwenbourg-Brzezinski, Acton Capital

A Principal at Acton Capital, Elisabeth Löwenbourg-Brzezinski aims to invest in game-changing companies and digitally native brands, including The Female Company, KOIO Collective and ArtNight. Prior to Acton Capital, she led a €200m coinvestment program at the European Investment Bank (EIB).

Profile Page

More DLD Talks

Journalist Andrian Kreye (Süddeutsche Zeitung) interviews Mark Surman, President of the Mozilla Foundation, at the DLD AI Summit 2023 in Munich.

The Future of AI, from an Open Source Perspective

Who controls AI, and how can the systems become more trustworthy? These questions lie at the heart of the DLD AI Summit discussion between Mark Surman, President of the Mozilla Foundation, and journalist…
Video Details
Yaakov Nahmias, founder of Tissue Dynamics, speaks with Jennifer Schenker of The Innovator about breakthroughs in biotechnology and medicine at DLD Munich

News in Drug Development & AI

Prof. Yaakov Nahmias is a bioengineer and innovator, whose breakthroughs ranged from the first 3D printing of cells to the first commercial human-on-chip technology. In this exciting fireside chat with Jennifer Schenker, Founder…
Video Details
magnifiercrosschevron-downchevron-rightmenu-circle
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram